Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.

PubWeight™: 2.63‹?› | Rank: Top 1%

🔗 View Article (PMID 12777852)

Published in Transplantation on May 27, 2003

Authors

Peter Abt1, Michael Crawford, Niraj Desai, James Markmann, Kim Olthoff, Abraham Shaked

Author Affiliations

1: Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.

Articles citing this

Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg (2011) 1.98

Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67

Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66

The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39

Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant (2012) 1.09

Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08

Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93

Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg (2005) 0.93

Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol (2004) 0.92

Liver transplantation: yesterday, today and tomorrow. World J Gastroenterol (2008) 0.88

Effects of warm ischemia time on biliary injury in rat liver transplantation. World J Gastroenterol (2012) 0.87

Dynamical changing patterns of glycogen and enzyme histochemical activities in rat liver graft undergoing warm ischemia injury. World J Gastroenterol (2005) 0.86

Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford) (2011) 0.84

Liver transplantation from non-heart beating donors. BMJ (2006) 0.84

Liver biochemistry profile, significance and endoscopic management of biliary tract complications post orthotopic liver transplantation. World J Gastroenterol (2007) 0.84

Non heart-beating donors in England. Clinics (Sao Paulo) (2008) 0.84

Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open (2013) 0.83

How important is donor age in liver transplantation? World J Gastroenterol (2016) 0.83

Endoscopic management of biliary complications after liver transplantation: An evidence-based review. World J Gastrointest Endosc (2015) 0.83

Establishment of a rat liver transplantation model with prolonged biliary warm ischemia time. World J Gastroenterol (2012) 0.82

Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int (2011) 0.81

Current diagnosis and treatment of benign biliary strictures after living donor liver transplantation. World J Gastroenterol (2016) 0.81

Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia. Gut Liver (2012) 0.80

Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol (2014) 0.80

Current status and recent advances of liver transplantation from donation after cardiac death. World J Gastrointest Surg (2011) 0.80

Developments in liver transplantation. Gut (2004) 0.79

Safe time to warm ischemia and posttransplant survival of liver graft from non-heart-beating donors. World J Gastroenterol (2004) 0.79

Fas mRNA expression and calcium influx change in H2O2-induced apoptotic hepatocytes in vitro. World J Gastroenterol (2005) 0.79

Management of Biliary Strictures After Liver Transplantation. Gastroenterol Hepatol (N Y) (2015) 0.78

Donation after cardio-circulatory death liver transplantation. World J Gastroenterol (2012) 0.78

Can controlled non-heart-beating donors provide a solution to the organ shortage? Transplantation (2003) 0.77

A meta-analysis of complications following deceased donor liver transplant. Am J Surg (2014) 0.77

Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford) (2011) 0.77

Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre. Can J Surg (2010) 0.76

The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors. PLoS One (2016) 0.76

Urokinase perfusion prevents intrahepatic ischemic-type biliary lesion in donor livers. World J Gastroenterol (2009) 0.76

Endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors. Can J Gastroenterol (2012) 0.75

Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies. J Clin Diagn Res (2015) 0.75

Timing of hepatic artery reperfusion and biliary strictures in liver transplantation. J Transplant (2013) 0.75

Neonatal and Pediatric Organ Donation: Ethical Perspectives and Implications for Policy. Front Pediatr (2015) 0.75

A case for stopping the early withdrawal of life sustaining therapies in patients with devastating brain injuries. J Intensive Care Soc (2016) 0.75

Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant (2017) 0.75

Articles by these authors

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20

Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16

Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology (2008) 2.95

Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med (2008) 2.83

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog (2009) 2.57

Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2012) 2.19

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95

Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72

Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2004) 1.68

Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 1.58

Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl (2010) 1.56

Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56

Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation (2004) 1.51

Usage and outcomes of deceased donor liver allografts with preprocurement injury from blunt trauma. Liver Transpl (2009) 1.45

A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford) (2012) 1.45

Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol (2012) 1.44

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. J Infect Dis (2011) 1.42

Ascites after liver transplantation--a mystery. Liver Transpl (2004) 1.40

Small bowel tumours: a 10 year experience in four Sydney teaching hospitals. ANZ J Surg (2004) 1.24

Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol (2003) 1.23

Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology (2002) 1.23

Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20

Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes (2010) 1.18

Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer (2010) 1.18

Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13

Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12

A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10

Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids (2006) 1.03

A significant role for histocompatibility in human islet transplantation. Transplantation (2006) 1.02

Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01

The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation (2002) 0.98

Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation (2007) 0.97

Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost (2005) 0.96

Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95

Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. Ann Surg (2015) 0.94

Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition. J Biol Chem (2010) 0.94

Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation (2002) 0.94

Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. Cancer (2011) 0.94

Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol (2005) 0.93

Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation (2004) 0.93

Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl (2012) 0.93

Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study. HPB (Oxford) (2014) 0.92

Birth and death of human β-cells in pancreases from cadaver donors, autopsies, surgical specimens, and islets transplanted into mice. Cell Transplant (2013) 0.92

Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance. Am J Clin Nutr (2005) 0.91

Late surgical complications following liver transplantation. Liver Transpl (2009) 0.90

Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells. Diabetes (2006) 0.89

Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology (2003) 0.89

Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant (2004) 0.88

Combined heart-liver transplant in a situs-ambiguous patient with failed Fontan physiology. J Thorac Cardiovasc Surg (2013) 0.87

Reclassifying personality disorders. Lancet (2011) 0.87

Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma. Ann Surg Oncol (2014) 0.87

Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl (2004) 0.86

Preoperative mapping venography in patients who require hemodialysis access: imaging findings and contribution to management. J Vasc Interv Radiol (2008) 0.86

Arterial vascular conduits in adult orthotopic liver transplant recipients. ANZ J Surg (2006) 0.86

Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) (2009) 0.85

Suicide in ethnic minority groups. Br J Psychiatry (2003) 0.85

Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries. J Surg Oncol (2013) 0.85

Delayed visual maturation in Karen refugee infants. Ann Trop Paediatr (2003) 0.84

Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl (2011) 0.84

Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation (2015) 0.84

Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma (2007) 0.84

Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids. Nutrition (2006) 0.84

The use of biological grafts for reconstruction of the inferior vena cava is a safe and valid alternative: results in 32 patients in a single institution. HPB (Oxford) (2013) 0.83

Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids (2005) 0.83

Appendicitis among liver transplant recipients. Liver Transpl (2005) 0.83

Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma. J Gastrointestin Liver Dis (2009) 0.83

Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery (2012) 0.83

The history and evolution of hand transplantation. Hand Clin (2011) 0.82

Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg (2015) 0.82

Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS). Prostaglandins Leukot Essent Fatty Acids (2005) 0.82

Early diagnosis and resection of an asymptomatic leiomyosarcoma of the inferior vena cava prior to caval obstruction. J Vasc Surg (2011) 0.82

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (2016) 0.82

Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease. Ann Hematol (2005) 0.82

Immunosuppression and hepatocellular carcinoma. Liver Transpl (2011) 0.82

Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg (2005) 0.82

Adult-adult living donor liver transplantation. J Gastrointest Surg (2004) 0.82

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study. Liver Transpl (2013) 0.81

Hepatic artery thrombosis and intraoperative hepatic artery flow rates in adult orthotopic liver transplantation. ANZ J Surg (2002) 0.81

Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data. Transplantation (2006) 0.81

Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol (2011) 0.81